Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002473245 | SCV002770159 | uncertain significance | not provided | 2022-12-22 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV005367797 | SCV006021653 | uncertain significance | Inborn genetic diseases | 2025-01-17 | criteria provided, single submitter | clinical testing | The c.4286C>T (p.P1429L) alteration is located in exon 25 (coding exon 25) of the KDM5C gene. This alteration results from a C to T substitution at nucleotide position 4286, causing the proline (P) at amino acid position 1429 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome |
RCV001249227 | SCV001423161 | not provided | Syndromic X-linked intellectual disability Claes-Jensen type | no assertion provided | phenotyping only | Variant interpretted as Uncertain significance and reported on 12-12-2018 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |